Manros Therapeutics

Biotechnology, Health Care
Founded in 2007-01-01
Roscoff, Bretagne, France
http://www.manros-therapeutics.com/
For Profit

About Manros Therapeutics

ManRos Therapeutics was founded in 2007 by Dr. Laurent Meijer (EC Director of Research, CNRS) and Pr. Hervé Galons (EC Professor, Université Paris-Descartes), two leading specialists in cellular and molecular biology and in organic chemistry, respectively. The objectives of ManRos Therapeutics are the identification, characterization, optimization (medicinal chemistry) and preclinical & clinical development of pharmacological kinase inhibitors (some derived from marine natural products) for their use in the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer’s disease.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 9 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: None USD
  • Last Funding: None (Venture - Series Unknown)
  • Funding Status:

Technology Stack

Manros Therapeutics actively uses 9 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care

Headquarters: Roscoff, Bretagne, France